Meet our 2025 EBPS Plenary Speakers and Awardees
2025 EBPS Awardees
Distinguished Achievement Award
Early Career Award
IDEA: Inclusion, Diversity, Equity and Accesibility
We are excited to introduce our upcoming EBPS IDEA event featuring keynote speaker Dr. Marian Joëls. Her book FINISHED (open access) highlights a range of dilemmas in the academic world:"The way we deal with frequently occurring situations in the academic world may not always be the only or even the best option. Too often, we—scientists—accept the situation as a given. “This is how the system works, and if you want to survive, you better adapt.” But we are the system and if particular aspects are wrong, we better mend them!...
Let the story foster a discussion with the ultimate goal of making the great world of science an even more excellent and enjoyable place to live"
Dr. Joëls will provide an overview of global issues related to inclusion, diversity, equity, and accessibility, examining both historical contexts and future directions. Following the keynote, a panel discussion will bring together panelists from diverse countries and career stages, fostering an open and dynamic conversation. This event aims to engage all attendees in meaningful discussions and collectively contribute to improving these critical issues in our society and beyond.
We have also planned round tables for discussion about the following topics: Work/life balance for women in science; Impostor syndrome; Language barriers as international scientist. We will open a link to submit discussion questions for the panelist ahead
Click on the tab to see the full programme in each day
8:30 - 9:15 Plenary lecture
Angela Roberts (UK)
Prefrontal regulation of emotion: insights into anhedonia, anxiety and pharmacotherapy
9:30 - 11:00 Featured Symposia 1
Global Perspectives on Neuropsychiatric Research: Stress, Cognition, and Innovative Therapeutics.
Chair: Princess Felix (USA)
Vidita Vaidya (India)
Neurocircuitry and Molecular Regulation of Stress and Emotion in Mood Disorders
Oritoke Okeowo (Nigeria)
Novel Pharmacological Approaches for Stress Related Disorders
Inna Gaisler-Salomon (Israel)
Transgenerational Stress and Glutamate Dysregulation in Cognitive Dysfunction
Gwladys Ngoupaye (Cameroon)
Cameroonian Medicinal Plants: Mechanistic Insights on Stress-Induced Cognitive Deficits
11:00 - 11:30 Coffee break
11:30 - 13:00 Parallel symposia
Symposium 1 · Endocannabinoids and sex-dependent behavior: Insights from development to adulthood
Chair: Carmen Sandi (Switzerland)
Miriam Mellis (Italy)
Sex-specific phenotypes induced by prenatal perturbation of endocannabinoid signaling
Olivier Manzoni (France)
Lifelong sex-specific impacts of prenatal cannabis exposure
Arnau Busquets Garcia (Spain)
Cannabinoid receptors and higher-order conditioning
Silvie Ruigrok (Switzerland)
Estrous cycle modulation of anxiety and motivation - focus on the endocannabinoid system
Symposium 2 ·Triggered Temptations: New Findings on How Environmental Cues Fuel Addiction and Gambling
Chair: Anna Samaha (Canada)
Anna Samaha (Canada)
Modeling cue-triggered relapse to cocaine use in rats
Muhammad Parvaz (USA)
Neurobiology of incubation of cue-reactivity in individuals with stimulants use disorders
Catharine Winstanley (Canada)
Win-paired cues drive risky choice through divergent mechanisms in male and female rats
Rajita Sinha (USA)
Drugs, Stress Cues or Both? Prospective effects on Craving and Drug Use in the Real World
Symposium 3 · A translational perspective on safety learning and safety behaviours
Chair: Joanna Yau (Australia)
Heidi Meyer (USA)
Experience with safety learning can scale later fear responding
Alba López Moraga (Belgium)
Differential effects of chronic stress on active avoidance procedures
Patrick Laing (USA)
Neural and behavioral mechanisms of Pavlovian safety learning
Sarah Tashjian (Australia)
vmPFC integration of safety information in humans
13:00 - 15:00 Lunch and Posters
15:00 - 16:30 Parallel Symposia
Symposium 4 · Innovations and Challenges of Psychedelics in Behavioral Health Disorders
Chair: Kathryn Cunningham (USA)
Kathryn Cunningham (USA)
Probing Mechanisms and Novel 5-HT2R Modulators as Psychedelic-Inspired Therapeutics for Cocaine Use Disorder
Charles Nichols (USA)
Novel 5-HT2A receptor agonists with treatment potential without acute behavioral effects
Friederike Holze (Switzerland)
Clinical pharmacology of different psychedelic drugs in healthy human volunteers
Leah Mayo (Canada)
Challenges and opportunities in psychedelic clinical trial design
Symposium 5 · Using Computational & Cognitive Methods to Study Substance Use Over the Addiction Course.
Chair: Justin Strickland (USA)
Justin Strickland (USA)
Evaluating Value-Based Decision-Making Mechanisms Underlying Opioid Use Disorder
Amber Copeland (UK)
Modelling Changes in Value-Based Decision-Making in Response to Contingency Management
Samuel Acuff (USA)
Exploring Trajectories Between Behavioral Economic Reward and Cannabis Use
José C. Perales (Spain)
The Role of Emotion Regulation Mechanisms in Gambling and Gaming Craving
Symposium 6 · Motivational and cognitive effects of manipulating the dopamine transporter: Potential therapeutic actions of atypical DAT inhibitors.
Chair: Mercè Correa (Spain)
Mercè Correa (Spain)
Vigor and work selection after bupropion administration in mice
John D. Salamone (USA)
Effort-related motivational effects of novel atypical DAT inhibitors in rats of both sexes
Jana Lubec (Austria)
Neurochemical, physiological, and cognitive effects of dopamine transporter inhibitors in aging rats
Marta Pardo (Spain)
DAT transgenic rats as a new model for vulnerability to stress
16:45 - 18:15 Parallel Symposia
Symposium 7 · From synapse to nucleus: an integrated view of neuronal ensembles
Chair: F. Javier Rubio (USA)
Eisuke Koya (UK)
Environmental enrichment suppresses food seeking and induces Prelimbic ensemble overdrive
Leslie Ramsey (USA)
Searching for the engram in prefrontal cortical neuronal ensembles: mechanisms that mediate drug and social learning
Sophie Tronel (France)
Looking for the engram of PTSD-like memory: focus on the role of NMDA receptors of the Anterior Cingulate cortex in traumatic memory maintenance
F. Javier Rubio (USA)
Plasticity changes in synapses from neuronal ensembles: seeking the synaptic ensemble
Symposium 8 · Pharmacology and Neural Mechanisms of Comorbid Pain and Drug Use
Chair: Nicholas W. Gilpin (USA)
Lucía Hipólito-Cubedo (Spain)
Modeling negative affective states comorbid with pain and drug intake: insights from rat models and translational perspectives
Jose Moron-Concepcion (USA)
Sex-specific effects of inflammatory pain on fentanyl self-administration and modulation by ovarian hormones
Joyce T. Da Silva (USA)
Periaqueductal Gray (PAG) Connectivity and Its Role in Chronic Pain and Addiction in Osteoarthritis: A Whole-Brain Approach
Nicholas W. Gilpin (USA)
Vaporized Cannabinoid Inhalation Effects on Chronic Inflammatory Pain Outcomes
Symposium 9 · Behavioural and neurobiological mechanisms of choice in rodent models of addiction
Chair: Nathan Marchant (Netherlands)
Nathan Marchant (Netherlands)
Role of anterior insula cortex in choice between alcohol and social reward
Marco Venniro (USA)
Neurobiological mechanisms mediating social and drug craving
Youna Vandaele (France)
Investigation of the decision-making processes underlying choice between drug and nondrug rewards
Jamie Peters (USA)
Mu opioid receptors and heroin vs. alcohol choice
18:30 - 19:30 Parallel Nanosymposia
Nanosymposium 1 · Amyotrophic lateral sclerosis: from the bench to the clinic
Chair: Santiago Mora (UK)
Xavier Navarro (Spain)
Pharmacological targeting Kv7 and TSPO as a therapeutical strategy for ALS
Silvia Corrochano (Spain)
Diet impact in modifying motor-cognitive phenotype in a mouse model of TDP43 proteinopathy
Beatriz Vélez-Gómez (Spain)
Comprehensive pharmacological approach in ALS: quality of life beyond motor symptoms
Ilary Allodi (UK)
Gene therapy strategies for the treatment of Amyotrophic Lateral Sclerosis
Nanosymposium 2 · Cannabinoid regulation of behaviour: addiction, cell specificity and development
Chair: Alejandro Higuera-Matas (Spain)
Luigi Bellocchio (France)
Cellular and Sub-cellular targets of cannabinoids: from signaling to behavior and beyond
Mireia Medrano (Spain)
The role of PPAR-gamma as a modulator of cocaine-seeking behaviour in male and female mice
Alejandro Higuera-Matas (Spain)
Exposure to cannabinoids during adolescence as a risk factor for psychopathology
Erika Zamberletti (Italy)
Sex-dependent consequences of adolescent exposure to different THC and CBD combinations
Nanosymposium 3 • Beyond D1 and D2 Dopamine Receptor-Expressing Neurons: Modulating Circuits and Behavior
Chair: Michelle W. Antoine (USA)
David Haggerty (USA)
D1/D2 Input to Npas1+ GPe Neurons Shapes Motor and Reward Actions
Bernard Le Foll (Canada)
Dopamine D3 Receptors in Nicotine Addiction: From Preclinical to Clinical Studies
Melissa Perreault (Canada)
Exploring the Functional Role of Gq-Coupled Dopamine Receptors in the Brain
Michelle W. Antoine (USA)
Roles of Striatal Neurons Co-Expressing Dopamine D1/D2 Receptors in Autism Mouse Models.
8:30 - 9:15 Plenary lecture
Marta Miquel (Spain)
Cerebellar modulation of drug-induced reward: How Cinderella came to the ball
9:30 - 11:00 Featured Symposia 2
Advanced Technologies and Big Data in Behavioral Pharmacology and Psychiatry
Chair: Brenda Curtis (USA)
Brenda Curtis (USA)
Digital Surveillance for Substance Use Trends: Social Media and Behavioral Data Analysis
Peter R. Chai (USA)
Smartphone phenotypes of PrEP adherence in substance use
Ignacio Obeso (Spain)
NeuroCognitive Dynamics in Pre-Addiction States Using Big Data and Neurotechnology
Stephanie Carreiro (Spain)
Wearable Sensors to Understand, Predict, and Respond to Substance Use Treatment
11:00 - 11:30 Coffee break
11:30 - 13:00 Parallel symposia
Symposium 10 · Recent advances in addiction vulnerability in animal models and humans
Chair: Yavin Shaham (USA)
Nazzareno Cannella (Italy)
Multisymptomatic screening reveals differences of addiction behavior and treatment outcome
Ginevra D’Ottavio (USA)
Exploring addiction vulnerability in preclinical models using drug vs social choice tasks
Irene Perini (Sweden)
Choice preference for alcohol over a natural reward in heavy versus light drinkers
Xiaosi Gu (USA)
A computational mechanism linking momentary craving and reward learning
Symposium 11 · Role of microglia in synaptic plasticity associated with substance use disorders
Chair: Ingrid Reverte (Italy)
Daniele Caprioli (Italy)
Microglia and AMPA receptor plasticity during cocaine withdrawal
Marie-Eve Tremblay (Canada)
The outcomes of cannabinoids and psychedelics on microglia
Jacqueline Barker (USA)
Neuroimmune mechanisms of dysregulated cocaine seeking in a mouse model of HIV infection
Liliana M. Cancela (Argentina)
Microglia and Glutamatergic Mechanisms in Stress-Induced Vulnerability to Cocaine Addiction
Symposium 12 · New insights on individual differences in pain and interoception using dense sampling techniques in humans. Chair: Siri Leknes (Norway)
Micah Allen (Denmark)
Brain-gut functional interactions in response to semagludide treatment: a dense sampling N-of-1 fMRI study
India Morrison (Sweden)
Iterative dyadic social interactions reveal context-sensitive neurohormonal changes
Karin Jensen (Sweden)
Neural learning mechanisms in the development of nociplastic pain: a dense sampling prospective longitudinal study of chronic non-specific pain
Marie Eikemo (Norway)
Predicting opioid responses and opioid use in surgery patients in the U.S. and Norway
13:00 - 15:00 Lunch and Posters
15:00 - 16:30 Parallel Symposia
Symposium 13 · The Stress of the Trip: Interactions between psychedelics and the stress response
Chair: Ana Deutsch (Canada)
Ana Deutsch (Canada)
The impact of LSD and MDMA on stress-related biomarkers & the eCB system in healthy humans
Sarah Gibson Cook (Canada)
Psilocybin induces sex- and context-specific recruitment of the stress axis
Helena Aicher (Switzerland)
Impact of Ayahuasca-Inspired DMT/Harmine Formulation on Stress Reactivity & the ANS in Healthy Humans
Margareth Nogueira (USA)
5-MeO-DMT effects on anxiety-related behavior and gene expression
Symposium 14 · Beyond Reward Prediction Error: translational conceptualizations, findings, and applications that shed a new light on dopamine’s function in complex behavior. Chair: Rita Goldstein (USA)
Vijay Mohan K Namboodiri (USA)
Extinction and retrospective learning
Geoffrey Schoenbaum (USA)
Striatal dopamine signals errors in cue prediction during sensory preconditioning
Rita Goldstein (USA)
Methylphenidate- and reconsolidation-enhanced drug memory forgetting in human addiction
Roshan Cools (Netherlands)
Role of dopamine in controllability inference for human cognitive control
Symposium 15 · Addictive Substances and Their Impact on Brain and Molecular Pathways
Chair: Mohamed Kabbaj (USA)
Stefania Maccari (France)
Prenatal stress effects on alcohol drinking: role of oxytocin and metabotropic receptors
Mary K Lobo (USA)
Perinatal fentanyl exposure impacts behavioral and brain molecular mechanisms
Mohamed Kabbaj (USA)
Role of medium spiny neurons in ketamine reinstatement
Marcelo Wood (USA)
Investigating the opposing roles of the nuclear orphan receptor NR4A2 in drug-seeking and relapse of drug-seeking
16:45 - 18:15 Parallel Symposia
Symposium 16 · Oxytocin: A promising old acquaintance
Chair: Rossella Ventura (Italy)
Valery Grinevich (Germany)
Oxytocin signaling in the prefrontal cortex
Inga D. Neumann (Germany)
Prosocial, anxiolytic, and Stress-protective effects of oxytocin in rodents
Bice Chini (Italy)
Long-lasting effects of Early life Oxytocin Administration in mice models of neurodevelopmental disorders
Simona Cabib (Italy)
Role of oxytocin in the development of the motivational salience neurocircuitry
Symposium 17 · New insights into neuromodulatory underpinnings of adaptive behaviour
Chair: Philip Jean-Richard-dit-Bressel (Australia)
Emmanuel Valjent (France)
Deconstructing the role of dopamine D2 receptors in motivated behaviors
Philip Jean-Richard-dit-Bressel (Australia)
Monoamine release during instrumental versus Pavlovian aversive learning
Laura Corbit (Canada)
Locus coeruleus activity promotes learning updates following changes in reward
Jay Bertran-Gonzalez (Australia)
At D2-neuron’s discretion: revealing dominant D2-to D1-neuron modulation in learning
Symposium 18 · The use of non-human primates in addiction-related research
Chair: Christelle Baunez (France)
Daniel Borgatti (USA)
Role of sleep disruption in cognitive impairment associated with methamphetamine use in rhesus monkeys
Paul Czoty (USA)
Nociceptin-orphanin FQ peptide (NOP) receptors as promising targets for substance use disorder medications: evidence from nonhuman primate models.
Christelle Baunez (France)
Motivation for cocaine is reduced by subthalamic nucleus deep brain stimulation in macaques
Anders Fink-Jensen (Denmark)
Effect of semaglutide and other glucagon-like peptide-1 (GLP-1) receptor agonists on alcohol consumption in alcohol-preferring vervet monkeys
18:30 - 19:30 Roundtable on animal research
18:30 - 19: 30 Roundtable IDEA
9:30 - 13:00 Pre-meeting workshop
From bench to bedside: how to improve the translational aspect of your research
Organized by Merce Correa (Spain)
Topics:
Applied behavioral and computational tools IA.
Laura Lopez Cruz, Anna Stuckert and Santiago Mora (United Kingdom).
How to deal with the pharma industry.
Trevor Robbins (United Kingdom) and John Salamone (USA).
12:00 - 15:00 Registration Opens
15:00 - 15:10 Welcome EBPS 2025
15:10 - 16:00 Travel Awardee Data Blitz
16:05 - 17:00 Panel discussion on Inclusion, Diversity, Equity and Accesibility
Marian Jöels (Netherlands)
17:00 - 17:30 Break and Mentor-Mentee meeting
17:30 - 19:00 Awardee Ceremony
Early career Investigator Award lecture Ida Fredriksson (Sweden)
The role of the ventral subiculum and claustrum in incubation of opioid craving
Distinguished Investigator Award lecture Dora Duka (United Kingdom)
A life on the borders of drug addiction
19:00 - 20:30 Opening Reception
9:00 - 9:45 Plenary Lecture
John Cryan (Ireland)
Bugs, drugs & behaviour: microbiome as a key regulator of brain function across the lifespan
10:00 - 11:30 Parallel symposia
Symposium 19 · The role of prefrontal cortical networks in flexible and compulsive reward-related behavior
Chair: Ingo Willuhn (Netherlands)
Alicia Izquierdo (USA)
Frontocortical circuits in learning under uncertainty
Ingo Willuhn (Netherlands)
Cortico-striatal circuits mediate compulsive behavior in schedule-induced polydipsia
Frank Meye (Netherlands)
A prefrontal cortex-lateral hypothalamus circuit controls stress-driven food intake
Stephanie Borgland (Canada)
Effect of astrocyte dysfunction in the OFC on goal-directed behaviour
Symposium 20 · The Dual Impact of Cannabis: Chronic and Acute Effects of Cannabinoids on Human Behaviour
Chair: Sara Kroll (Switzerland)
Lukas Eggenberger (Switzerland)
Linking THC and CBD Hair Analytes to Cognitive and Mental Health Outcomes
Ziva Cooper (USA)
Sex-dependent effects of cannabis: Does use frequency impact outcomes?
Amir Englund (UK)
The interactive effects of THC and CBD in healthy volunteers and schizophrenia patients
Connor Haggarty (USA)
Harnessing the cannabinoid system for the treatment of PTSD
Symposium 21 · Neurohormonal dysregulations underlying alcohol and opioid use disorders
Chair: Brendan Tunstall (USA)
Brendan Tunstall (USA)
Oxytocin against hyperalgesia and intensified alcohol drinking in alcohol dependence
Kristen Pleil (USA)
Estrogen enhancement of risky alcohol drinking behavior
Brandon Warren (USA)
Novel MOR-partial agonist against opioid self-administration, withdrawal, and pain
Hayley Manke (USA)
Role of PKCε in Alcohol Dependence
11:30 - 12:00 Coffee break
12:00 - 13:30 Parallel symposia
Symposium 22 · New therapies for psychostimulant addiction
Chairs: Malgorzata Filip/Christian P. Müller (Poland/Germany)
Malgorzata Filip (Poland)
Cocaine seeking during abstinence: effects of esketamine and Tat-NR2B9c peptide
Judith R. Homberg (Netherlands)
Controlling cocaine reward and self-administration by targeting dopaminergic and serotonergic storage vesicles
Rainer Spanagel (Germany)
Cell type-specific multi-omics analysis of cocaine use disorder in the addiction circuitry reveals new drug targets addiction circuitry reveals new drug targets
Christian P. Müller (Germany)
The pharmacotherapy of psychostimulant use disorders – past, present, and future ideas
Symposium 23 · Sex Differences in the Risk, Pathophysiology, and Treatment of Neuropsychiatric Disorders
Chair: Christina Dalla (Greece)
Debra Bangasser (USA)
Sex differences in the effects of early resource scarcity on motivated behavior
Christina Dalla (Greece)
Sex differences in psycho-pharmacological effects of GPER1 estrogen membrane receptor
Patrizia Campolongo (Italy)
Sex differences in fear expression and persistence in an animal model of PTSD
Ivan Nalvarte (Sweden)
Sex hormones, gender, and the aging brain
Symposium 24 · Uncovering the behavioral and biological factors underlying individual differences in risk for alcohol use disorder. Chair: Andrew Holmes (USA)
Esi Domi (Italy)
Individual differences and neural substrates in compulsive alcohol self- administration
Anna Beyeler (France)
Contribution of the insular cortex to persistent alcohol drinking in mice
Andrew Holmes (USA)
Artificial intelligence-based prediction of individual differences in mouse alcohol binge-drinking
Markus Heilig (Sweden)
Massive single-nucleus transcriptional profiling reveals a novel molecular substrate of compulsive alcohol use
13:30 - 14:00 EBPS Assembly and Closing Remarks
14:00 - 14:30 EBPS Executive Committee Meeting (by invitation including new members)
POSTER SESSION 1 Thursday, 18th September • 13:00-15:00
P1.1 Ines Erkizia-Santamaria (Spain)
Endogenous serotonin modulates psychedelic-like effects of psilocybin in mice
P1.2 Margareth Lima (USA)
Therapeutic effects of the psychedelic 5-MeO-DMT in opioid use disorder
P1.3 Cristina Izquierd Luengo (Spain)
Unraveling the 5-HT2C receptor’s role in somatosensory filtering: implications in psychosis and therapeutic potential
P1.4 Nathaniel Kregar (USA)
Psilocybin disrupts heroin cue reactivity in prefrontal cortex neuronal ensembles
P1.5 Jordi Jornet-Plaza (Spain)
Signs of antidepressant-like effects following adolescent ketamine in selectively bred low-responder rats
P1.6 Elena Hernández Hernández (Spain)
Characterization of the acute effects of psilocybin in male and female aging mice
P1.7 Adiia Stone (Canada)
Challenges with the use of sweet additives in an oral morphine self-administration task in male and female rats
P1.8 Hayley Thorpe (Canada)
Cadm2 gene knockout in mice modifies cannabinoid response and preference, and affects the electrophysiological properties of prelimbic cortical neurons
P1.9 Irene Garcia Manzanares (Spain)
Novel behavioral approaches to evaluate psychotic-like states induced by Delta-9-Tetrahidrocannabinol in mice
P1.10 Valeria Serra (Italy)
Role of the lateral hypothalamus in the hyperdopaminergic phenotype induced by prenatal THC exposure
P1.11 Roberta Leone (Italy)
Dysregulation of tryptophan metabolism and the disinhibition of dopamine neurons induced by in utero cannabis exposure
P1.12 Lucía Cárcel Valle (Spain)
Modulation of Anxiety by Cannabidiol in a Chronic Mild Stress Model
P1.13 Laura Galvez Melero (Spain)
A preclinical study evaluating the impact of temozolomide on affective- and cognitive-like responses in adult rats of both sexes
P1.14 Abanoub Armanious (Australia)
Sigma-1 receptor antagonism reduces palatable food-seeking in female rats with binge-eating history and high-fat diet exposure
P1.15 Ana Belén Sanz Martos (Spain)
Tributyrin reverses the deleterious effect of saturated fat on memory and plasticity in juvenile mice in a sex dependent manner
P1.16 Antonio Pérez-Colorado (Spain)
Chronic methylphenidate consumption during adolescence reduces parvalbumin neurons in prelimbic and disrupt long-term attentional maintenance
P1.17 Reyes Martinez Marin (Spain)
Behavioral Effects of Different Methylphenidate Doses on Fear Conditioning and Locomotor Activity in Adolescent and Adult Wistar Rats: Sex-Specific Differences
P1.18 Tylah Doolan (Australia)
Deciphering the involvement of the Paraventricular Nucleus in Oxytocin’s regulation of methamphetamine addiction behaviours: A Chemogenetic Approach
P1.19 Joel Raymond (USA)
Stimulant solutions, sleepless nights: dexamphetamine and lisdexamfetamine suppress binge eating but disrupt sleep in female rats
P1.20 Alice Minard (France)
Role of the olfactory system in the vulnerability to flavored nicotine addiction in electronic cigarettes
P1.21 Anita Sikic (Canada)
Discriminative and proteomic effects of nicotine vs cigarette smoke extract in rats
P1.22 Yaiza Jiménez Marín (Spain)
Ascertaining the behavioral responses induced by different anesthetic drugs administered during adolescence in rats of both sexes
P1.23 Spatika Jayaram (UK)
Critical periods of development across prefrontal sub-regions: insights from magnetic resonance spectroscopy in marmosets
P1.24 Sofia Vellere (Italy)
Adolescent social exclusion and fear of missing out on the vulnerability to alcohol and stress-related disorders: a preclinical approach
P1.25 Camilla Mancini (Italy)
The role of oxytocin in mediating long-term consequences of early attachment disruption
P1.26 Ann-Sofie Bjerre (Australia)
Neural Signatures of Social Reward: Oxytocin and Dopamine Signalling in the Nucleus Accumbens
P1.27 Giulia Federica Mancini (Italy)
Late treatment with mifepristone counteracts behavioral effects of brief and repeated social isolation stress in adolescent rats
P1.28 Neda Assareh (Australia)
Whole brain activity mapping of the effects of a novel small molecule on chronic social isolation-induced aggression in mice
P1.29 Oliver Tan (Australia)
Differing neural pathways underpin divergent peripheral vasopressin actions in resident-intruder and neutral context models of aggression in isolated and group housed mice
P1.30 Marta Pardo (Spain)
Transgenic DAT Rat Model Reveals Vulnerability to Early Life Stress and Protective Effects of Exercise on Neurobehavioral Outcomes
P1.31 Oritoke Okeowo (Nigeria)
Chronic unpredictable stress alters social behavior in adult male rats: association with serotonergic and dopaminergic changes
P1.32 Alberto Fernández Teruel (Spain)
Neonatal handling modulates behavioral and neurobiological processes in a genetic rat model of schizophrenia: Age- and strain-dependent effects on frontocortical neuroplasticity
P1.33 Wei-li Chang (USA)
Neural signatures of impaired behavioral discrimination in the ventral hippocampal CA1 after early life adversity in mice
P1.34 Víctor Ferrís Vilar (Spain)
Effect of peripheral inflammatory insults on anxiety-like behaviour and microglial responses within the mesocorticolimbic system
P1.35 Amber Besseling (UK)
Effects of sex and inhibitory neuron type on fear memory suppression by extinction
P1.36 Valeria Tarmati (Italy)
Genotype-Dependent Functional Role of the Anterior and Posterior Paraventricular Thalamus in the Incubation of Conditioned Fear
P1.37 Meghan McDermott (Ireland)
The Gut Microbiota Shapes the Endocannabinoid System Throughout Development
P1.38 Lucas Hassib Camina (Brazil)
Involvement of Gut Microbiota in the Behavioral Therapeutic Effects of Cannabidiol in an Autism Animal Model
P1.39 Samin Davoody (Iran)
Gut-brain axis modulation by Limosilactobacillus reuteri in a maternal separation animal model of autism: exploring underlying mechanisms
P1.40 Carla Ramon Duaso (Spain)
Astrocyte Dynamics in Alzheimer’s Disease: Unraveling Sex-, Genotype-, and Cannabinoid-Dependent Mechanisms
P1.41 Lorena Roselló-Jiménez (Spain)
Noradrenaline and the astrocyte-neuron lactate shuttle: The critical role of β2-adrenergic receptors in glycogenolysis and object recognition memory in female mice
P1.42 Serafina Manila Guzzo (Italy)
Guanidinoacetate methyltransferase deficiency in mice: a window into behavioral dysfunction and RNA therapy potential
P1.43 Amelie Essmann (USA)
Deciphering the effects and neurochemical identity of projections into the nucleus accumbens
P1.44 Javier Cuitavi (Ireland)
Age-related changes in the metabolic and cognitive effects of systemic Tumour Necrosis Factor α
P1.45 Yury Lages (France)
miR-10a-5p Modulates Impulsive Choice in Rats: Insights into the Role of PI3K and the AKT/MTOR Pathway
P1.46 Brianna Ramos (USA)
Identifying a neurochemical signature of the paraventricular nucleus of the thalamus that predicts individual variability in cue-reward learning
P1.47 Zuzana Pedan (UK)
Sex differences in the role of cue-reactive nucleus accumbens neuronal ensembles in spontaneous recovery of food seeking
P1.48 Princess Felix (USA)
Knockdown of the glucocorticoid receptor (GR) in a corticostriatal pathway increases the propensity to attribute incentive salience to a reward cue
P1.49 Alicja Bryk (Poland)
Study of potential behavioral predictors of obesity phenotypes in male rats
P1.50 Merridee Lefner (USA)
Distinct roles for ventral tegmental area GABA and dopamine neurons underlying flexible updating of reward and punishment contingencies
P1.51 Christakis Kagios (Sweden)
Effects of cafeteria diet on pituitary hormones and behaviour in male Wistar rats
P1.52 Matthew Bailey (UK)
Inhibitory Brain Dynamics for Adaptive Behaviour: The Role of GABAergic Neurotransmission in Temporal Discrimination based Visual Perceptual Learning
P1.53 Matthew Hilton (UK)
The effects of selective serotonin reuptake inhibitors and beta-blockers on learning in dynamically changing environments
P1.54 Rita El Azali (Canada)
Individual differences in sensitivity and resistance to punished self-administration of a sweetened oral morphine solution
P1.55 Stephanie Desrochers (USA)
Differential engagement of top-down and bottom-up pathways in the paraventricular thalamus in sign-trackers versus goal-trackers
P1.56 Alexandra Gregory (Australia)
Brain networks for punishment learning
P1.57 Kendra Loedige (Canada)
Parsing the role of Cell Adhesion Molecule 2 in externalizing traits using Pavlovian conditioning and RNA sequencing in transgenic mice
P1.58 Zengyou Ye (USA)
An open-source, budget-friendly tail suspension test platform with high temporal resolution for behavioral and neural correlation studies
P1.59 Davin Peart (Canada)
Neural substrates of potentiation of cocaine-primed reinstatement by 17β-estradiol in ovariectomized rats
P1.60 Iva Tic (USA)
TRPV1 antagonism modulates drug-seeking behavior in cocaine self-administration in male but not female mice
P1.61 Natalia Morales Pagán (USA)
The impact of a GLP-1 receptor agonist on cue- and drug-induced reinstatement of cocaine-seeking behavior
P1.62 Jeanne-Laure de Peretti (France)
Can correlated pathological oscillations in the cortex and the subthalamic nucleus predict compulsive-like cocaine seeking in rats?
P1.63 Veronika Llerena (USA)
PPAR-gamma agonism induces distinctive effects on cocaine-reinforced behaviour in male and female mice
P1.64 Cristian Bis-Humbert (Spain)
Increased vulnerability to cocaine addiction in male rats exhibiting maladaptive sucrose self-administration behavior
P1.65 Maria Carolina Machado da Silva (Brazil)
Disruption of immune homeostasis mediates neural and behavioral alterations induced by cocaine
P1.66 Maria Ros (Spain)
Effect of isolation and binge alcohol drinking in decision-making behaviour rats: study of the sex and age differences
P1.67 Javier Orihuel Menéndez (Spain)
A Senotherapeutic approach alleviate alcohol-induce cellular damage and reduce compulsive like alcohol consumption in mice
P1.68 Leandro Ruiz Leyva (USA)
Therapeutic potential of an ibogaine analog for polydrug opioid and alcohol misuse
P1.69 Sofie van Koppen (Netherlands)
Effects of age of onset of voluntary alcohol consumption on reward sensitivity, impulsivity, and cognitive flexibility in rats
P1.70 Jairo Steffan Acosta Vargas (Spain)
Long-term effects of adolescent THC-CBD vapor exposure on alcohol-related behaviour: evidence from schedule-induced polydipsia and self-administration paradigms
P1.71 Bart Cooley (Australia)
Satiety-related treatments on alcohol motivation and choice
P1.72 Lauri Elsilä (Finland)
Voluntary ethanol consumption disrupts circadian rhythm in female mice: preliminary observations exploring the utility of automated home cage monitoring
P1.73 Lauren Ursich (Australia)
Assessing the utility of zuranolone to modify alcohol-related behaviours
P1.74 Esther Visser (Sweden)
PKC-δ neurons in the central amygdala promote compulsive alcohol use
P1.75 Carles Colom-Rocha (Spain)
Adolescent alcohol or cocaine exposure enhances addictive-like behaviors and impairs early stages of hippocampal neurogenesis in male and female adult rats
P1.76 Jonathan Aguirre (USA)
Effect of ventral tegmental area dopamine neuron inhibition on stress-induced reinstatement
P1.77 Andrea Coppola (Sweden)
A role for social status and social status loss in alcohol-related behaviors in Wistar male and female rats
P1.78 Keira Aubin (Canada)
Exploring the relationship between early-life trauma, circulating endocannabinoids, and problematic cannabis use among young adults
P1.79 Zachary Pierce-Messick (USA)
Effect of nicotine dose and dose expectancy on puff- and bout-level analysis of smoking topography
P1.80 Abigail Lunge (Canada)
The impact of childhood maltreatment on the endocannabinoid system and the processing of socially relevant information in healthy humans
P1.81 Marc D. Ferger (Canada)
Longitudinal Changes in Endocannabinoids and Clinical Course in Adolescents with Non-Suicidal Self-Injury
P1.82 Berta Escudero (Spain)
Longitudinal changes in apolipoproteins correlate with alterations in cognitive decline in alcohol use disorder: a prospective cohort study
P1.83 Luis Contreras (Canada)
Exploring Access to Psychedelics Among Canadian Veterans: Pathways, Barriers, and Experiences
P1.84 Rocío Rodríguez-Herrera (Spain)
Neurofunctional Mechanisms of Behavioural Inhibition in ADHD and OCD: A Comparative Study Using the Stop-Signal Task and Resting-State Functional Connectivity
P1.85 Sara Alaeddin (Australia)
Can faecal microbiota transplantation improve cognitive function in mild cognitive impairment?
P1.86 Thomas Zandonai (Italy)
Co-prescription of anticholinergics and benzodiazepines in chronic pain patients treated with opioids: a population-based case-control study
P1.87 Paula Banca (Spain)
Action-sequence learning, habits and automaticity in obsessive-compulsive disorder: implications for treatment
P1.88 Tania Romacho (Spain)
Repurposing antidepressants for diabetic neuropathic pain: in combination or alone?
P1.89 Páleníček Tomáš (CZ)
The effects of Ayahuasca on inter-brain synchrony during the ritual in the Amazon – a field study
P1.90 Tatum Sevenoaks (UK)
The effect of caffeine consumption and acute withdrawal on mood, cognition, and resting state brain activity
POSTER SESSION 2 Friday, 19th September • 13:00-15:00
P2.1 Harry Robson (UK)
Investigating the role of the alpha-7 nicotinic acetylcholine receptor during a signal detection task: pharmacological modulation and molecular analysis
P2.2 Marion Annie Ponserre (Germany)
GlyT1 inhibitor, Bitopertin redistributes the excitatory and inhibitory network connectivity in mouse medial prefrontal cortex
P2.3 Elena Fiori (Italy)
From prefrontal cortex to behavioral: a novel characterization of phenilalanine sensitivity in two mice models of phenylketonuria
P2.4 Maria Llach Folcrà (USA)
Behavioral and molecular effects of CBD in a peripartum depression mouse model
P2.5 Zheng-Xiong Xi (USA)
Brain CB2 Receptor: A New Target in Medication Development for Treating Opioid Use Disorder in Rodents
P2.6 Courtney S. Wilkinson (USA)
Is there a role for extended amygdala dynorphin/κ-opioid receptor in opioid addiction-like behaviors?
P2.7 Alexander Athanasopoulos (Australia)
Exploring behavioural interactions between methamphetamine and psilocybin in mouse models of methamphetamine sensitization and head twitch response
P2.8 Álvaro López Villegas (Spain)
Effects of the 5-HT2A agonist DOI on compulsivity and reversal learning in preclinical models
P2.9 Itziar Beruete Fresnillo (Spain)
Characterizing the antidepressant-like effects of psilocybin in adolescent rats of both sexes
P2.10 Judit Biosca Brull (Spain)
Transcriptomic and metabolomic signatures of ibogaine treatment: preclinical and clinical investigation
P2.11 Maria Asuncion Aguilar (Spain)
Ketamine prevented the anxiety- and depression-like symptoms and the enhanced sensitivity to cocaine induced by social defeat in mice
P2.12 Olivia Gilmore McKimm (Australia)
Acute and enduring effects of psilocybin on EEG power spectra and sleep architecture in mice
P2.13 Pedro Bergas-Cladera (Spain)
Exploring the Prosocial Impact of Psilocybin in Male and Female Adult Mice
P2.14 Annika Hästbacka Schäfer (Finland)
BDNF/TrkB signalling in tolerance development to diazepam in mice
P2.15 Gladys Pinto (Spain)
Cognitive and emotional consequences of new psychoactive substances chronic use: investigation with Alkyl Nitrites (Poppers)
P2.16 Nerea Ríos Nieto (Spain)
Comparative Effects of Serotonergic and Glutamatergic Modulators to remediate behavioral alterations in anhedonia, anxiety and compulsivity in preclinical models
P2.17 Satoshi Ikemoto (US)
Reinforcing effects of nicotine in the hypothalamic supramammillary region involve activation of glutamatergic projections to the medial septum
P2.18 Livia Wilod Versprille (UK)
Amphetamine selectively reduces dopamine transients in the nucleus accumbens core during decision-making and distraction in a visual signal detection task
P2.19 Roberto Alvarez (Spain)
Psychedelics, Stimulants, and Habituation: Behavioral Effects of DOI and Amphetamine in the Earthworm Dendrobaena veneta
P2.20 Maria Zelai Garçon (USA)
Inflammatory cytokine profile in plasma and brain during chronic pain progression
P2.21 Natalia de las Heras Martínez (Spain)
Maternal immune activation and vulnerability to develop adjunctive behaviours in adulthood: an exploratory study
P2.22 Antonino Casile (Italy)
Dysregulation of the oxytocin system and disruption of social reward processing in a rat model of gaming disorder
P2.23 Gregorio Sonsini (Italy)
An efficient raw pixel approach for machine learning-based annotation of novel object recognition videos
P2.24 Fernando Sánchez-Santed (Spain)
A Systematic Review Focused on Micro-/Nano-Plastic Developmental Neurotoxicity. In Search for Common
Biological Target Across Different Models
P2.25 Michele Petrella (Sweden)
Dissecting the role of lateral septum PKCδ neurons
P2.26 Andrea Sepe (Italy)
Genotype-dependent corticolimbic network differences in cue-induced fear responses: A Data-Driven c-Fos-based analysis
P2.27 Antonio Cañete Ramírez (Spain)
Cognitive Impairments in the RHA vs RLA rats: Insights into Schizophrenia-Related Deficits
P2.28 Daniel Sampedro Viana (Spain)
Neonatal Handling Enhances Exploratory and Social Behaviour, and Neuroplasticity in a genetic rat model of Schizophrenia-relevant traits
P2.29 Antonio José Rodríguez Sánchez (Spain)
Anodal tDCS improves anxiety-like behavior in rats with ischemic stroke
P2.30 Bianca Bobotis (Canada)
Sex chromosomes and sex hormones differently shape microglial properties during normal physiological conditions in the adult mouse hippocampus
P2.31 Bianca De Filippis (Italy)
In search of molecular signatures preceding full symptoms appearance: towards early interventions for Rett syndrome
P2.32 Diana Cardona (Spain)
Influence of ingestion of live microalgae rich in omega-3 acids on biochemistry, behaviour and gut microbiota in mice
P2.33 Ketki Mulay (Ireland)
Sex-specific effects of gut microbial depletion on adult hippocampal neurogenesis and spatial and contextual memory
P2.34 Elena Martín-González (Spain)
Brain metabolomic alterations in compulsive rats selected by Schedule-Induced Polydipsia
P2.35 Ewa Litwa (Poland)
Effects of deep brain stimulation on BDNF-ERK-CREB signaling pathway in animal model of treatment-resistant depression
P2.36 Ezgi Selcuk Filizoglu (Spain)
The D3 receptor knock-out mutation in dopamine deficient aphakia mice reverses activational impairments: impact on the cerebral dopamine neurotrophic factor
P2.37 Francesca Sansó-Elle (Spain)
Validating a preclinical model of PMDD in female Sprague-Dawley rats
P2.38 María Jose Simón (Spain)
Conditioned Place Aversion induced by electrical stimulation of the Lateral Parabrachial Area is blocked by selective mu-opioid antagonists
P2.39 Margarita Moreno Montoya (Spain)
Habits Study Network in Experimental Psychology
P2.40 Pedro Vidal (Spain)
Time-based diminishing returns task: Effects of d-amphetamine on decision-making strategies under multiple schedules
P2.41 Rocío Rodulfo (Spain)
Enhancing Impulsivity Assessment in Mice: Validation of the Variable Delay-to-Signal Task
P2.42 Blanca Cativiela Campos (Spain)
Where you live matters: air pollution affects cognitive and emotional health along with changes in the inflammatory response during aging
P2.43 Elena Tittarelli (Italy)
MicroRNA-34a as a Possible Functional Marker of the Innate Freezing Defensive Response
P2.44 Heidi Lesscher (Netherlands)
Sleep Deprivation and risky play during early life: Implications for cognitive control in rats
P2.45 Isabel Galiana Camacho (Spain)
Impact of Combined Prenatal Exposure to Chlorpyrifos and Particulate Matter on Early Neurodevelopmental Outcomes in Wistar Rats
P2.46 José Miguel Rosales Pérez (Spain)
Impact of Maltodextrin on Gut-Brain Axis
P2.47 Mario Ruiz Coca (Spain)
Long-Term Effects of Prenatal Exposure to PM10 and Chlorpyrifos in Aging: Impact on Memory and Hippocampal Gene Expression in Offspring
P2.48 Paula Matas Navarro (Spain)
Aphakia dopamine deficient mice show anergia but not anhedonia: the role of cerebral dopamine neurotrophic factor in dopaminergic terminal areas
P2.49 Stephanie Borgland (Canada)
Effect of astrocyte dysfunction in the orbitofrontal cortex on goal-directed behaviour
P2.50 Kelly Zhuang (Australia)
A cognitive pathway to maladaptive choice
P2.51 Amanda C. Lee (UK)
Outcomes of CADM2 recursive splice site variation on rodent neuroimaging and ADHD-related behaviours
P2.52 Matthew C. Broomer (USA)
Neural representation of altered reward-seeking behavior following punishment
P2.53 Elisa Marín-Sampietro (Spain)
Cerebellar modulation in cocaine self-administration and drug-seeking behavior
P2.54 Claudia Fornari (France)
Role of progesterone on cue-induced cocaine seeking in rats
P2.55 Giulia De Maio (France)
Knock-down of the histone methyltransferase Prdm2 in the dorsomedial prefrontal cortex: effect on cocaine-related behaviors in male rats
P2.56 Hannah L. Robinson (USA)
Effects of chemogenetic modulation of the mesocorticolimbic dopamine pathway on cocaine choice
P2.57 M. Flavia Barbano (US)
Role of Dorsal Raphe glutamatergic neurons in cocaine-seeking behavior
P2.58 Oscar Solis Castrejon (US)
Synaptic zinc and dopamine dynamics in response to cocaine and locomotion
P2.59 Abel Fabrega Leal (Spain)
Role of cerebellum projecting neurons to the VTA in cocaine-induced conditioned memory
P2.60 Palmira Acosta Mares (Italy)
Impulsivity as a risk factor for Alcohol Use Disorders: Development and validation of a Go-NoGo Model of Impulsivity
P2.61 Paula Andres Herrera (Spain)
Inflammatory pain impairs alcohol reward processing without affecting motivation for sucrose or alcohol in female rats
P2.62 Tetiana Kardash (Sweden)
The role of a positive allosteric modulator of the GABAB receptor (ADX71441) on ethanol vapor dependence-induced compulsive alcohol drinking
P2.63 Eva Bonilla González (Spain)
Sexual dimorphism in the behavioural impact of binge drinking during adolescence
P2.64 Francisca Carvajal (Spain)
Modulation of binge-like consumption of ethanol and other salient reinforcers by acute DHA administration in C56BL/6J mice
P2.65 Hannah Machet (Australia)
Decision-making in electric barrier-induced voluntary abstinence
P2.66 Jolanta Kotlinska (Poland)
New preclinical research on pathogenesis of fetal alcohol spectrum disorders: The role of myelination and endocannabinoids
P2.67 José Manuel Lerma-Cabrera (Spain)
Neuroprotective effects of chronic DHA on ethanol intake in a mouse model of adolescent alcohol exposure
P2.68 Leticia Lopez Valencia (Spain)
Functional consequences of apolipoprotein AI potentiation in females exposed to intensive alcohol consumption
P2.69 Manuela Olmedo Córdoba (Spain)
Combined 5-HT2A Receptor Agonist and Anodal tDCS for Modulating Compulsive Alcohol Drinking in a Preclinical Model
P2.70 Mara Morales González (Spain)
Compulsivity and Alcohol Abuse: Sexual Dimorphism and Disruption of Social Interaction in a Preclinical Model
P2.71 Mateo Leganes-Fonteneau (Belgium)
Mapping acute alcohol effects on bodily sensations
P2.72
P2.73 Cecilia Bergeria (USA)
Examining the Relationship between Drug Demand, Craving, and Withdrawal during a Buprenorphine Taper among Individuals with Opioid Use Disorder
P2.74 Darío Puertas-López (Spain)
Learning contingencies and uncertainty: a modified probabilistic reversal learning task
P2.75 Suky Martinez (USA)
Emerging evidence of heterogeneity in the opioid withdrawal syndrome: spontaneous and precipitated withdrawal
P2.76 Neus Ibáñez Sempere (Spain)
Decision-Making in ADHD and OCD: A Transdiagnostic Approach Using the Iowa Gambling and Delay Discounting Tasks
P2.77 Diego Ruiz (Spain)
Variability in cognitive reserve across the aging process: structural equation modeling evidence based on rural contexts and sociodemographic determinants
P2.78 Isabell Meier (Norway)
Endogenous opioid modulation of safety learning in humans
P2.79 Jose Manuel Cimadevilla (Spain)
Differential brain activity between young and older adults associated with performance on a spatial recognition task
P2.80 Laura Brandt (USA)
From clinical trials to real-world impact: introducing a computational framework to detect endpoint bias in opioid use disorder research
P2.81 Lola Rueda (Spain)
Effects of a multi-strain probiotic on mental and emotional health in older adults: a randomized crossover study
P2.82 María Luisa Ruiz Franco (Spain)
Treatment of apathy in stroke patients. A systematic review
P2.83 Thomas Zandonai (Italy)
The Emergence of Ketamine Use as an Adjunct to Physical Exercise: A Netnographic Analysis